MichaelCMiloneMD
Pathology • Philadelphia, PABlood Banking & Transfusion Medicine, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology & Laboratory Medicine, Perelman School of Medicine
Dr. Milone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6503- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 2002 - 2003- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2000 - 2002
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1999 - 2000
Rutgers New Jersey Medical SchoolClass of 1999
Certifications & Licensure
PA State Medical License 2002 - 2024- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies.Zhang, Z., Markmann, C., Yu, M., Agarwal, D., Rostami, S., Wang, W., Liu, C., Zhao, H., Ochoa, T., Parvathaneni, K., Xu, X., Li, E., Gonzalez, V., Khadka, R., Hoffmann...> ;Cell Reports. Medicine. 2023 Dec 19
- F77 antigen is a promising target for adoptive T cell therapy of prostate cancer.Payal Grover, Selene Nunez-Cruz, John Leferovich, Tyra Wentz, Atrish Bagchi, Michael C Milone, Mark I Greene> ;Biochemical and Biophysical Research Communications. 2023 Nov 5
- 22 citationsPrecision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel, Eun Jung Choi, Andrea Alvarado, Ebony Cottman-Thomas, Damian Maseda, Patricia Y Tsao, Chris...> ;Nature Biotechnology. 2023 Sep 1
- Join now to see all
Journal Articles
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersMatthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
- CAR T Cell Immunotherapy for Human CancerCarl H June, Michael C Milone, Science Magazine
- High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelStephan A Grupp, Zissimos Mourelatos, Michael C Milone, David M Barrett, Sarah A Richman, Clinical Cancer Research
Lectures
- Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia a2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Penn Medicine Breakthrough Immunotherapy Technique Could Reduce Cost of Cancer TreatmentApril 12th, 2022- Research Roundup: Scientists May Have Solved CAR-T Turnaround ChallengeApril 1st, 2022
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of PhiladelphiaAugust 30th, 2017- Join now to see all
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Pennsylvania HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
